Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Bangladesh Health Times.
Fortified Rice Market Valued at USD 18.2 Bn in 2022, Set to Grow at a 5.7% CAGR by 2031 | TMR
EIN Presswire
·
December 16, 2024
Fortified rice is enriched with essential vitamins and minerals to combat malnutrition and improve public health. WILMINGTON, DE, UNITED STATES, December 16, 2024 /EINPresswire.com/ -- The global fortified rice market is poised for significant...
Western AI installs values
MENAFN
·
July 7, 2025
(MENAFN) As generative AI spreads across the Global South, it increasingly serves as a subtle tool of Western influence, embedding foreign ideologies and infrastructure while sidelining local knowledge systems, languages, and traditions. These AI...
Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
GlobeNewswire, Inc.
·
March 18, 2025
HYDERABAD, India and REYKJAVIK, Iceland, March 18, 2025 (GLOBE NEWSWIRE) -- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”) and Alvotech...
DimHum Launches Revolutionary CrowdShipping Service
EIN Presswire
·
July 3, 2025
DimHum is not just a shipping solution, it is creating a global community of trust, connection, and support. NEW YORK, NY, UNITED STATES, July 3, 2025 /EINPresswire.com/ -- DimHum Inc., an innovative global crowdshipping startup platform,...
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
GlobeNewswire, Inc.
·
February 21, 2025
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination of interchangeability for SELARSDI SELARSDI is...
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
GlobeNewswire, Inc.
·
February 21, 2025
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination of interchangeability for SELARSDI SELARSDI is...
Functional Food Products Market Size is Expected to Reach USD 382.28 Billion by 2033, Growing at a CAGR of 8.22%: Market Strides
GlobeNewswire, Inc.
·
March 26, 2025
New York, United States, March 26, 2025 (GLOBE NEWSWIRE) -- As per the Latest Report by Market Strides, The global functional food products market size, valued at approximately USD 203.2 billion in 2024, is projected to reach around USD 382.28...
Dig In! Moley Leads the Charge for Global Action Days
GlobeNewswire, Inc.
·
April 24, 2025
London, April 24, 2025 (GLOBE NEWSWIRE) -- Get ready to stomp, soak, drum and dance — because Global Action Days has officially begun, and it’s all happening beneath our feet! Kicking off on Earth Day and continuing for two action-packed weeks,...
Thinning Machine Market Set to Hit $3.8 Billion by 2034 with 6.1% CAGR | Exactitude Consultancy
GlobeNewswire, Inc.
·
June 2, 2025
Luton, Bedfordshire, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- Market Overview The global thinning machine market is valued at approximately $2.1 billion in 2024 and is forecast to grow at a CAGR of 6.1%, reaching about $3.8 billion by...
Remittance Market Set for Strong Growth Through 2032 Amid Rising Cross-Border Payments and Financial Inclusion Efforts
EIN Presswire
·
June 27, 2025
Remittance Market Set for Strong Growth Through 2032 Amid Rising Cross-Border Payments and Financial Inclusion Efforts NEW CASTLE, DE, UNITED STATES, June 27, 2025 /EINPresswire.com/ -- Allied Market Research published a report, titled,...
How the environment is silently shaping your risk for cancer
University of Chicago Medicine
·
November 12, 2024
Cancer occurs when genetic changes disrupt cells’ normal functions. These genetic mutations can be inherited, happen spontaneously when cells make copies of themselves, or be caused by environmental carcinogens — chemicals capable of causing...
Playing For Change Foundation Partners with Shawn Mendes to Expand Music Education Access for Youth Worldwide
GlobeNewswire, Inc.
·
June 25, 2025
Miami, June 25, 2025 (GLOBE NEWSWIRE) -- Playing For Change Foundation (PFCF), the global nonprofit transforming lives through music and arts education, is excited to announce its partnership with The Shawn Mendes Foundation (SMF) to bring music...
Global Zinc Market Outlook 2025-2034: Growth Drivers, Share, And Trends
EIN Presswire
·
June 5, 2025
The Business Research Company's Global Zinc Market Outlook 2025-2034: Growth Drivers, Share, And Trends LONDON, GREATER LONDON, UNITED KINGDOM, June 5, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market...
GPPC's Three-Pronged Strategy Aims to Overcome Market Headwinds
EIN Presswire
·
June 20, 2025
New Product Lines Reinforce Sustainable Green Petrochemical Development TAIPEI, TAIWAN, June 20, 2025 /EINPresswire.com/ -- Grand Pacific Petrochemical Corporation (GPPC, 1312) held its annual shareholders’ meeting today (June 20). During the...
Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI™ (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara® (ustekinumab)
GlobeNewswire, Inc.
·
October 22, 2024
Approval of SELARSDI 130 mg/26 mL in a single-dose vial for intravenous infusion expands label to include treatment of adults with Crohn’s disease and ulcerative colitis The FDA previously approved SELARSDI 45 mg/0.5 mL and 90 mg/mL in a...
Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI™ (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara® (ustekinumab)
GlobeNewswire, Inc.
·
October 22, 2024
Approval of SELARSDI 130 mg/26 mL in a single-dose vial for intravenous infusion expands label to include treatment of adults with Crohn’s disease and ulcerative colitis The FDA previously approved SELARSDI 45 mg/0.5 mL and 90 mg/mL in a...
Indigo Dyes Market Expected to Achieve a Strong 5.06% CAGR, to Reach USD 9.5 Billion by 2032
EIN Presswire
·
January 16, 2025
Growing demand for natural dyes Increasing use in textile industry Rising consumer awareness Technological advancements Expanding applications in pharmaceutical NY, UNITED STATES, January 16, 2025 /EINPresswire.com/ -- Indigo dyes, historically...
Global Decorticator Machine Market Flourishes with Cannabis Legalization and Eco-Friendly Fiber Demand
EIN Presswire
·
June 2, 2025
Decorticator machines are vital for processing fiber crops like hemp, driving efficiency and sustainability in textiles, bioplastics, and industrial materials. NEWARK, DE, UNITED STATES, June 3, 2025 /EINPresswire.com/ -- The global Decorticator...
Alvotech Reports Financial Results for the First Nine Months of 2024
GlobeNewswire, Inc.
·
November 13, 2024
Total Revenues in the first nine months of 2024 increased by $300 million compared to same period in 2023, to $339 million, with Q3 revenues contributing $103 million Product revenues in the first nine months of 2024 increased over four-fold...
AIDA Country Report on Ireland – 2024 Update
European Council on Refugees and Exiles (ECRE)
·
June 9, 2025
|Published on: 9th June 2025|Categories: News| The updated AIDA Country Report on Ireland provides a detailed overview on legislative and practice-related developments in asylum procedures, reception conditions, detention of asylum applicants and...